Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd. (India) holds 0 active US FDA Type II Drug Master Files and 2 inactive and has DMF or CEP filings on record for 1 active ingredient. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Jagsonpal Pharmaceuticals Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/jagsonpal-pharmaceuticals-ltd

Overview

Jagsonpal Pharmaceuticals Ltd. is a pharmaceutical company headquartered in Gurugram, India.

Active ingredients with DMF or CEP filings

Substances for which Jagsonpal Pharmaceuticals Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Jagsonpal Pharmaceuticals Ltd. holds 0 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • D-OXYPHENEInactive2006-07-27
  • TRIMETHOPRIMInactive1985-04-10

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2025-02-05

    FDA Warning Letter (drug product)

For suppliers

Is this Jagsonpal Pharmaceuticals Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.